A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer (Q36610100)

From Wikidata
Jump to navigation Jump to search
scientific article published on 27 February 2007
edit
Language Label Description Also known as
English
A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer
scientific article published on 27 February 2007

    Statements

    A phase II study of capecitabine and irinotecan in combination with concurrent pelvic radiotherapy (CapIri-RT) as neoadjuvant treatment of locally advanced rectal cancer (English)
    F Willeke
    K Horisberger
    U Kraus-Tiefenbacher
    A Leitner
    R Grobholz
    A Willer
    G Kähler
    S Post
    R-D Hofheinz
    27 February 2007
    912-917

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit